Definitely, if they can reduce costs and time dramatically...

Definitely, if they can reduce costs and time dramatically through this device then MEM is really onto something special, seems like it can be readily and easily distributed to IVF clinics globally too since it is such a small device.

I found this on the University of Newcastle website too, seems professor Aitken felt his CS10 device would be able to capture a significant portion of a $100million market (2015), the same device which has now been repurposed and improved by MEM
(as referred to in the September investor presentation - skip to 7:35 in this vid for anyone who hasn't watched it yet, Alison pulls out Aitken's CS10 device and refers to it and its previous issues, https://www.finnewsnetwork.com.au/P...torEvents_2018/04Sep/Memphasys_MEM/index.html) .

"His research led to the development of a separating device called the CS10, manufactured in conjunction with life sciences company NuSep. Set for a commercial launch in 2015, it has the potential to snare a substantial share of the world market estimated to be worth more than $100 million a year."

https://www.newcastle.edu.au/profile/john-aitken

MEM has come along and attempted to fix the issues that Aitken and his team ran into with the CS10 device. If their device works then there is huge potential in this device to capture the $100million market referred to by Aitken previously and even more as referred to in the presentation.